SCHEMBL8478679

SCHEMBL8478679

CCOC(=O)C(=O)C(Cc1cc2c(cc1Cl)OCO2)C(=O)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.41
NPC1 O15118 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 3/20 0.41
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 2/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 2/20 0.36
TP53 P04637 1/20 0.36
BRS3 P32247 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6943904 0.91 CYP3A4 (0.44) RAB9ANPC1SMN1; SMN2MAPTCRHBP
SCHEMBL6940934 0.88 CYP3A4 (0.42) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL10871043 0.87 CYP3A4 (0.46) RAB9ANPC1SMN1; SMN2MAPTCRHBP
SCHEMBL8480946 0.85 RAB9A (0.41) RAB9ANPC1SMN1; SMN2MAPTCRHBP
SCHEMBL8477041 0.83 RAB9A (0.42) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL15261862 0.78 CYP3A4 (0.55) SMN1; SMN2MAPTCYP3A4CYP2C9CYP1A2
SCHEMBL8477323 0.75 SMN1; SMN2 (0.42) RAB9ANPC1SMN1; SMN2MAPTCRHBP
SCHEMBL8021852 0.75 CYP1A2 (0.40) RAB9ANPC1SMN1; SMN2MAPTCRHBP
SCHEMBL7472228 0.74 CYP1A2 (0.38) CYP3A4CYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL6600354 0.74 ALDH1A1 (0.45) RAB9ANPC1SMN1; SMN2MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5942622-A NOVEL COMPOUNDS FOR TREATING ILLNESS RESULTING FROM ABNORMAL STIMULATION OF ENDOTHELIAL RECEPTORS; FOR EXAMPLE: 4-((6-CHLORO-1,3-BENZODIOXOL-5-YL)METHYL)-1-(CYCLOHEXYLMETHYL) -3-(2-PYRIDINYL)-1H-PYRAZOLE-5-CARBOXYLATE HOECHST MARION ROUSSEL (FR) 1999-08-24 US disclosed